- Amicus Therapeutics ( NASDAQ: FOLD ) is scheduled to announce FY earnings results on Wednesday, March 1st, before market open.
- The consensus EPS Estimate is -$0.79 (+14.1% Y/Y) and the consensus Revenue Estimate is $328.9M (+7.7% Y/Y).
- Over the last 1 year, FOLD has beaten EPS estimates 25% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 1 upward revision and 1 downward. Revenue estimates have seen 4 upward revisions and 4 downward.
For further details see:
Amicus Therapeutics FY 2022 Earnings Preview